13G Filing: Rock Springs Capital Management and Ardelyx Inc. (ARDX)
Ardelyx Inc. (NASDAQ:ARDX): Kris Jenner, Gordon Bussard and Graham Mcphail’s Rock Springs Capital Management filed an amended 13D. You can check......(read more)
Posts Tagged ‘Ardelyx Inc (ARDX)’
13G Filing: James E. Flynn and Ardelyx Inc. (ARDX)
Ardelyx Inc (NASDAQ:ARDX): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
Here’s What The Latest Ardelyx Inc (ARDX) Data Means For The Company Going Forward
Ardelyx Inc (NASDAQ:ARDX) just put out data from a phase III study in patients with end stage renal disease, and the company is running up on the back......(read more)
RA Capital’s Top Q2 Performers; Predicts Big Things Ahead for Pharma Stocks
RA Capital Management LLC is a crossover fund manager that invests in public and private healthcare and life science companies developing drugs, medical......(read more)
Ardelyx (ARDX): RA Capital Management Boosts Stake to 7.7%
Peter Kolchinsky‘s RA Capital Management has stepped up its interest in Ardelyx Inc. (NASDAQ:ARDX). As reported in a recent filing with the Securities......(read more)
Massive Insider Buying Witnessed at 3 Companies, Including This Fresh Acquisition Target
High-ranking executives have more knowledge and insight concerning the state of their companies, the market conditions within their industries, and possible......(read more)
Here’s Why Investors Are Piling Into These Five Stocks
With the VIX fear index retreating by 6.6% today and volatility calming down a bit, investors are snapping up NGL Energy Partners LP (NYSE:NGL), Boyd......(read more)
Delta Air Lines Inc. (DAL), Ardelyx Inc. (ARDX) & Exa Corp (EXA) Witnessing Insider Buying Activity
Unquestionably, most companies’ officers and directors have more up-to-date insights about their companies’ ongoing challenges, future prospects and......(read more)
Ardelyx Inc (ARDX): RA Capital Management Discloses 7.3% Passive Stake
RA Capital Management, led by Peter Kolchinsky, has opened a new position in clinical-stage biopharmaceutical company Ardelyx Inc (NASDAQ:ARDX). A new......(read more)
